Shares of CVS Health surged in premarket trading Wednesday after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results.
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI report weighed on the interest rate outlook.
When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback